Versor Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Versor Investments's BMY Position: Q1 2026 in Review
Versor Investments sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 9,206 shares — an estimated $497K sold.
Versor Investments first reported a position in BMY in Q3 2018 and held it in 18 quarters. The position peaked at $2.91M in Q2 2022. 2,532 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Versor Investments reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- Versor Investments sold 9,206 Bristol-Myers Squibb shares in Q1 2026, an estimated $497K.
- Versor Investments first reported a position in Bristol-Myers Squibb in Q3 2018 and held it in 18 quarters.
- Versor Investments's Bristol-Myers Squibb position peaked at $2.91M in Q2 2022.
- 2,532 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.